Other

97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407

Volume: 16, Issue: 4, Pages: S748 - S749
Published: Mar 27, 2021
Paper Details
Title
97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407
Published Date
Mar 27, 2021
Volume
16
Issue
4
Pages
S748 - S749
© 2025 Pluto Labs All rights reserved.